nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—ABCB1—Desloratadine—allergic rhinitis	0.0615	0.0866	CbGbCtD
Temsirolimus—CYP2D6—Desloratadine—allergic rhinitis	0.0579	0.0816	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Hydrocortisone—allergic rhinitis	0.0402	0.0567	CbGbCtD
Temsirolimus—CYP3A7—Hydrocortisone—allergic rhinitis	0.0402	0.0567	CbGbCtD
Temsirolimus—CYP3A4—Flunisolide—allergic rhinitis	0.0368	0.0519	CbGbCtD
Temsirolimus—ABCB1—Loratadine—allergic rhinitis	0.0353	0.0497	CbGbCtD
Temsirolimus—CYP3A4—Olopatadine—allergic rhinitis	0.0346	0.0488	CbGbCtD
Temsirolimus—CYP2D6—Loratadine—allergic rhinitis	0.0333	0.0469	CbGbCtD
Temsirolimus—CYP2D6—Diphenhydramine—allergic rhinitis	0.0333	0.0469	CbGbCtD
Temsirolimus—ABCB1—Methylprednisolone—allergic rhinitis	0.0323	0.0455	CbGbCtD
Temsirolimus—CYP3A5—Hydrocortisone—allergic rhinitis	0.0302	0.0425	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dexamethasone—allergic rhinitis	0.025	0.0352	CbGbCtD
Temsirolimus—CYP3A7—Dexamethasone—allergic rhinitis	0.025	0.0352	CbGbCtD
Temsirolimus—CYP3A4—Loratadine—allergic rhinitis	0.0211	0.0298	CbGbCtD
Temsirolimus—CYP3A4—Montelukast—allergic rhinitis	0.0211	0.0298	CbGbCtD
Temsirolimus—ABCB1—Betamethasone—allergic rhinitis	0.021	0.0296	CbGbCtD
Temsirolimus—ABCB1—Prednisolone—allergic rhinitis	0.0207	0.0292	CbGbCtD
Temsirolimus—ABCB1—Hydrocortisone—allergic rhinitis	0.0196	0.0277	CbGbCtD
Temsirolimus—CYP3A4—Methylprednisolone—allergic rhinitis	0.0193	0.0273	CbGbCtD
Temsirolimus—CYP3A5—Dexamethasone—allergic rhinitis	0.0188	0.0264	CbGbCtD
Temsirolimus—CYP3A4—Triamcinolone—allergic rhinitis	0.0147	0.0207	CbGbCtD
Temsirolimus—CYP3A4—Betamethasone—allergic rhinitis	0.0126	0.0177	CbGbCtD
Temsirolimus—CYP3A4—Prednisolone—allergic rhinitis	0.0124	0.0175	CbGbCtD
Temsirolimus—ABCB1—Dexamethasone—allergic rhinitis	0.0122	0.0172	CbGbCtD
Temsirolimus—CYP3A4—Hydrocortisone—allergic rhinitis	0.0118	0.0166	CbGbCtD
Temsirolimus—CYP2D6—Dexamethasone—allergic rhinitis	0.0115	0.0162	CbGbCtD
Temsirolimus—CYP3A4—Dexamethasone—allergic rhinitis	0.00732	0.0103	CbGbCtD
Temsirolimus—MTOR—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.00173	0.0954	CbGpPWpGaD
Temsirolimus—MTOR—respiratory system—allergic rhinitis	0.00129	0.0962	CbGeAlD
Temsirolimus—MTOR—eye—allergic rhinitis	0.00118	0.0879	CbGeAlD
Temsirolimus—FKBP1A—respiratory system—allergic rhinitis	0.00116	0.0865	CbGeAlD
Temsirolimus—MTOR—epithelium—allergic rhinitis	0.00108	0.0804	CbGeAlD
Temsirolimus—FKBP1A—eye—allergic rhinitis	0.00106	0.0791	CbGeAlD
Temsirolimus—MTOR—skin of body—allergic rhinitis	0.00103	0.0765	CbGeAlD
Temsirolimus—FKBP1A—epithelium—allergic rhinitis	0.000973	0.0723	CbGeAlD
Temsirolimus—FKBP1A—bronchus—allergic rhinitis	0.000958	0.0712	CbGeAlD
Temsirolimus—FKBP1A—skin of body—allergic rhinitis	0.000925	0.0688	CbGeAlD
Temsirolimus—FKBP1A—trachea—allergic rhinitis	0.00086	0.064	CbGeAlD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000803	0.0444	CbGpPWpGaD
Temsirolimus—MTOR—Type II diabetes mellitus—ADIPOQ—allergic rhinitis	0.000767	0.0424	CbGpPWpGaD
Temsirolimus—MTOR—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.000757	0.0419	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—SMAD3—allergic rhinitis	0.000734	0.0406	CbGpPWpGaD
Temsirolimus—MTOR—lung—allergic rhinitis	0.000687	0.0511	CbGeAlD
Temsirolimus—MTOR—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.000639	0.0353	CbGpPWpGaD
Temsirolimus—FKBP1A—lung—allergic rhinitis	0.000618	0.046	CbGeAlD
Temsirolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFB1—allergic rhinitis	0.000541	0.0299	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—CCL11—allergic rhinitis	0.000512	0.0283	CbGpPWpGaD
Temsirolimus—CYP3A5—respiratory system—allergic rhinitis	0.000507	0.0377	CbGeAlD
Temsirolimus—FKBP1A—TGF-beta receptor signaling—SMAD3—allergic rhinitis	0.000498	0.0275	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000483	0.0267	CbGpPWpGaD
Temsirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—allergic rhinitis	0.000435	0.0241	CbGpPWpGaD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SMAD3—allergic rhinitis	0.000393	0.0217	CbGpPWpGaD
Temsirolimus—FKBP1A—ALK1 signaling events—TGFB1—allergic rhinitis	0.000367	0.0203	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL5—allergic rhinitis	0.000346	0.0191	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000343	0.019	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFB1—allergic rhinitis	0.000311	0.0172	CbGpPWpGaD
Temsirolimus—MTOR—AMPK Signaling—ADIPOQ—allergic rhinitis	0.000307	0.017	CbGpPWpGaD
Temsirolimus—ABCB1—respiratory system—allergic rhinitis	0.000269	0.02	CbGeAlD
Temsirolimus—CYP3A5—lung—allergic rhinitis	0.000269	0.02	CbGeAlD
Temsirolimus—FKBP1A—Spinal Cord Injury—IL4—allergic rhinitis	0.000261	0.0144	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—IL10—allergic rhinitis	0.000253	0.014	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—IL4—allergic rhinitis	0.000252	0.014	CbGpPWpGaD
Temsirolimus—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000252	0.000975	CcSEcCtD
Temsirolimus—Asthenia—Loratadine—allergic rhinitis	0.000252	0.000974	CcSEcCtD
Temsirolimus—Insomnia—Montelukast—allergic rhinitis	0.000251	0.000968	CcSEcCtD
Temsirolimus—Abdominal distension—Triamcinolone—allergic rhinitis	0.000249	0.000964	CcSEcCtD
Temsirolimus—Abdominal distension—Methylprednisolone—allergic rhinitis	0.000249	0.000962	CcSEcCtD
Temsirolimus—MTOR—Costimulation by the CD28 family—HLA-DQB1—allergic rhinitis	0.000249	0.0137	CbGpPWpGaD
Temsirolimus—Influenza—Triamcinolone—allergic rhinitis	0.000248	0.000957	CcSEcCtD
Temsirolimus—Somnolence—Montelukast—allergic rhinitis	0.000246	0.000952	CcSEcCtD
Temsirolimus—MTOR—IL4-mediated signaling events—IL4—allergic rhinitis	0.000246	0.0136	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—NFKB1—allergic rhinitis	0.000246	0.0136	CbGpPWpGaD
Temsirolimus—Upper respiratory tract infection—Hydrocortisone—allergic rhinitis	0.000245	0.000945	CcSEcCtD
Temsirolimus—Hypersensitivity—Cetirizine—allergic rhinitis	0.000243	0.000941	CcSEcCtD
Temsirolimus—Diarrhoea—Loratadine—allergic rhinitis	0.00024	0.000928	CcSEcCtD
Temsirolimus—Hypersensitivity—Flunisolide—allergic rhinitis	0.000239	0.000925	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000239	0.000924	CcSEcCtD
Temsirolimus—Fatigue—Montelukast—allergic rhinitis	0.000239	0.000923	CcSEcCtD
Temsirolimus—Dry skin—Betamethasone—allergic rhinitis	0.000238	0.000921	CcSEcCtD
Temsirolimus—Dry skin—Dexamethasone—allergic rhinitis	0.000238	0.000921	CcSEcCtD
Temsirolimus—Bronchitis—Triamcinolone—allergic rhinitis	0.000238	0.000921	CcSEcCtD
Temsirolimus—Weight decreased—Hydrocortisone—allergic rhinitis	0.000238	0.00092	CcSEcCtD
Temsirolimus—Asthenia—Cetirizine—allergic rhinitis	0.000237	0.000916	CcSEcCtD
Temsirolimus—Pain—Montelukast—allergic rhinitis	0.000237	0.000916	CcSEcCtD
Temsirolimus—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000237	0.000915	CcSEcCtD
Temsirolimus—Hypokalaemia—Betamethasone—allergic rhinitis	0.000237	0.000915	CcSEcCtD
Temsirolimus—Infestation—Hydrocortisone—allergic rhinitis	0.000235	0.000906	CcSEcCtD
Temsirolimus—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000235	0.000906	CcSEcCtD
Temsirolimus—Pruritus—Cetirizine—allergic rhinitis	0.000234	0.000903	CcSEcCtD
Temsirolimus—Conjunctivitis—Prednisolone—allergic rhinitis	0.000233	0.000902	CcSEcCtD
Temsirolimus—Asthenia—Flunisolide—allergic rhinitis	0.000233	0.000901	CcSEcCtD
Temsirolimus—Dizziness—Loratadine—allergic rhinitis	0.000232	0.000897	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	0.00023	0.00089	CcSEcCtD
Temsirolimus—Pruritus—Flunisolide—allergic rhinitis	0.00023	0.000888	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000227	0.000875	CcSEcCtD
Temsirolimus—Diarrhoea—Cetirizine—allergic rhinitis	0.000226	0.000874	CcSEcCtD
Temsirolimus—MTOR—Regulation of Telomerase—SMAD3—allergic rhinitis	0.000226	0.0125	CbGpPWpGaD
Temsirolimus—ABCB1—epithelium—allergic rhinitis	0.000225	0.0167	CbGeAlD
Temsirolimus—Vomiting—Loratadine—allergic rhinitis	0.000223	0.000863	CcSEcCtD
Temsirolimus—Diarrhoea—Flunisolide—allergic rhinitis	0.000222	0.000859	CcSEcCtD
Temsirolimus—Rash—Loratadine—allergic rhinitis	0.000221	0.000856	CcSEcCtD
Temsirolimus—Dermatitis—Loratadine—allergic rhinitis	0.000221	0.000855	CcSEcCtD
Temsirolimus—Infestation NOS—Methylprednisolone—allergic rhinitis	0.00022	0.000852	CcSEcCtD
Temsirolimus—Infestation—Methylprednisolone—allergic rhinitis	0.00022	0.000852	CcSEcCtD
Temsirolimus—Headache—Loratadine—allergic rhinitis	0.00022	0.00085	CcSEcCtD
Temsirolimus—Body temperature increased—Montelukast—allergic rhinitis	0.000219	0.000846	CcSEcCtD
Temsirolimus—Abdominal pain—Montelukast—allergic rhinitis	0.000219	0.000846	CcSEcCtD
Temsirolimus—Dizziness—Cetirizine—allergic rhinitis	0.000218	0.000844	CcSEcCtD
Temsirolimus—MTOR—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000215	0.0119	CbGpPWpGaD
Temsirolimus—Dizziness—Flunisolide—allergic rhinitis	0.000215	0.00083	CcSEcCtD
Temsirolimus—Conjunctivitis—Triamcinolone—allergic rhinitis	0.000215	0.00083	CcSEcCtD
Temsirolimus—FKBP1A—TGF-beta receptor signaling—TGFB1—allergic rhinitis	0.000211	0.0117	CbGpPWpGaD
Temsirolimus—Vomiting—Cetirizine—allergic rhinitis	0.00021	0.000812	CcSEcCtD
Temsirolimus—Nausea—Loratadine—allergic rhinitis	0.000209	0.000806	CcSEcCtD
Temsirolimus—Epistaxis—Triamcinolone—allergic rhinitis	0.000208	0.000805	CcSEcCtD
Temsirolimus—Rash—Cetirizine—allergic rhinitis	0.000208	0.000805	CcSEcCtD
Temsirolimus—Dermatitis—Cetirizine—allergic rhinitis	0.000208	0.000804	CcSEcCtD
Temsirolimus—FKBP1A—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000208	0.0115	CbGpPWpGaD
Temsirolimus—Headache—Cetirizine—allergic rhinitis	0.000207	0.0008	CcSEcCtD
Temsirolimus—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000207	0.0008	CcSEcCtD
Temsirolimus—Vomiting—Flunisolide—allergic rhinitis	0.000207	0.000798	CcSEcCtD
Temsirolimus—Rash—Flunisolide—allergic rhinitis	0.000205	0.000792	CcSEcCtD
Temsirolimus—Dermatitis—Flunisolide—allergic rhinitis	0.000205	0.000791	CcSEcCtD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	0.000205	0.0113	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Montelukast—allergic rhinitis	0.000204	0.000789	CcSEcCtD
Temsirolimus—Headache—Flunisolide—allergic rhinitis	0.000204	0.000786	CcSEcCtD
Temsirolimus—Weight decreased—Dexamethasone—allergic rhinitis	0.000203	0.000786	CcSEcCtD
Temsirolimus—Weight decreased—Betamethasone—allergic rhinitis	0.000203	0.000786	CcSEcCtD
Temsirolimus—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000203	0.000784	CcSEcCtD
Temsirolimus—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000203	0.000784	CcSEcCtD
Temsirolimus—ABCB1—trachea—allergic rhinitis	0.000199	0.0148	CbGeAlD
Temsirolimus—Rhinitis—Triamcinolone—allergic rhinitis	0.000199	0.000768	CcSEcCtD
Temsirolimus—Asthenia—Montelukast—allergic rhinitis	0.000199	0.000768	CcSEcCtD
Temsirolimus—Rhinitis—Methylprednisolone—allergic rhinitis	0.000198	0.000766	CcSEcCtD
Temsirolimus—Pharyngitis—Triamcinolone—allergic rhinitis	0.000197	0.00076	CcSEcCtD
Temsirolimus—Eye disorder—Hydrocortisone—allergic rhinitis	0.000197	0.00076	CcSEcCtD
Temsirolimus—Nausea—Cetirizine—allergic rhinitis	0.000196	0.000758	CcSEcCtD
Temsirolimus—Pruritus—Montelukast—allergic rhinitis	0.000196	0.000757	CcSEcCtD
Temsirolimus—Conjunctivitis—Dexamethasone—allergic rhinitis	0.000195	0.000753	CcSEcCtD
Temsirolimus—Conjunctivitis—Betamethasone—allergic rhinitis	0.000195	0.000753	CcSEcCtD
Temsirolimus—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000194	0.000751	CcSEcCtD
Temsirolimus—Nausea—Flunisolide—allergic rhinitis	0.000193	0.000746	CcSEcCtD
Temsirolimus—Immune system disorder—Hydrocortisone—allergic rhinitis	0.00019	0.000735	CcSEcCtD
Temsirolimus—Diarrhoea—Montelukast—allergic rhinitis	0.00019	0.000733	CcSEcCtD
Temsirolimus—Erythema—Prednisolone—allergic rhinitis	0.000188	0.000725	CcSEcCtD
Temsirolimus—MTOR—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	0.000187	0.0103	CbGpPWpGaD
Temsirolimus—Eye disorder—Methylprednisolone—allergic rhinitis	0.000185	0.000714	CcSEcCtD
Temsirolimus—Mental disorder—Hydrocortisone—allergic rhinitis	0.000184	0.000713	CcSEcCtD
Temsirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—allergic rhinitis	0.000184	0.0102	CbGpPWpGaD
Temsirolimus—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000184	0.00071	CcSEcCtD
Temsirolimus—Malnutrition—Hydrocortisone—allergic rhinitis	0.000183	0.000708	CcSEcCtD
Temsirolimus—Erythema—Hydrocortisone—allergic rhinitis	0.000183	0.000708	CcSEcCtD
Temsirolimus—Dizziness—Montelukast—allergic rhinitis	0.000183	0.000708	CcSEcCtD
Temsirolimus—Angiopathy—Methylprednisolone—allergic rhinitis	0.00018	0.000694	CcSEcCtD
Temsirolimus—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000179	0.000691	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000178	0.000689	CcSEcCtD
Temsirolimus—Vomiting—Montelukast—allergic rhinitis	0.000176	0.000681	CcSEcCtD
Temsirolimus—Rash—Montelukast—allergic rhinitis	0.000175	0.000675	CcSEcCtD
Temsirolimus—Dermatitis—Montelukast—allergic rhinitis	0.000175	0.000674	CcSEcCtD
Temsirolimus—Headache—Montelukast—allergic rhinitis	0.000174	0.000671	CcSEcCtD
Temsirolimus—Mental disorder—Methylprednisolone—allergic rhinitis	0.000173	0.00067	CcSEcCtD
Temsirolimus—Erythema—Triamcinolone—allergic rhinitis	0.000173	0.000667	CcSEcCtD
Temsirolimus—Erythema—Methylprednisolone—allergic rhinitis	0.000172	0.000666	CcSEcCtD
Temsirolimus—Malnutrition—Methylprednisolone—allergic rhinitis	0.000172	0.000666	CcSEcCtD
Temsirolimus—Angioedema—Prednisolone—allergic rhinitis	0.000172	0.000663	CcSEcCtD
Temsirolimus—Dysgeusia—Triamcinolone—allergic rhinitis	0.000169	0.000653	CcSEcCtD
Temsirolimus—Eye disorder—Betamethasone—allergic rhinitis	0.000168	0.00065	CcSEcCtD
Temsirolimus—Eye disorder—Dexamethasone—allergic rhinitis	0.000168	0.00065	CcSEcCtD
Temsirolimus—Angioedema—Hydrocortisone—allergic rhinitis	0.000168	0.000647	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	0.000167	0.00926	CbGpPWpGaD
Temsirolimus—Back pain—Triamcinolone—allergic rhinitis	0.000167	0.000645	CcSEcCtD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—allergic rhinitis	0.000166	0.00919	CbGpPWpGaD
Temsirolimus—Nausea—Montelukast—allergic rhinitis	0.000165	0.000636	CcSEcCtD
Temsirolimus—Angiopathy—Betamethasone—allergic rhinitis	0.000163	0.000631	CcSEcCtD
Temsirolimus—Angiopathy—Dexamethasone—allergic rhinitis	0.000163	0.000631	CcSEcCtD
Temsirolimus—Convulsion—Prednisolone—allergic rhinitis	0.000163	0.000628	CcSEcCtD
Temsirolimus—Hypertension—Prednisolone—allergic rhinitis	0.000162	0.000626	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.00016	0.00883	CbGpPWpGaD
Temsirolimus—Convulsion—Hydrocortisone—allergic rhinitis	0.000159	0.000614	CcSEcCtD
Temsirolimus—Hypertension—Hydrocortisone—allergic rhinitis	0.000158	0.000612	CcSEcCtD
Temsirolimus—Angioedema—Triamcinolone—allergic rhinitis	0.000158	0.000609	CcSEcCtD
Temsirolimus—Angioedema—Methylprednisolone—allergic rhinitis	0.000157	0.000608	CcSEcCtD
Temsirolimus—Erythema—Dexamethasone—allergic rhinitis	0.000157	0.000605	CcSEcCtD
Temsirolimus—Erythema—Betamethasone—allergic rhinitis	0.000157	0.000605	CcSEcCtD
Temsirolimus—Myalgia—Hydrocortisone—allergic rhinitis	0.000156	0.000603	CcSEcCtD
Temsirolimus—Anxiety—Hydrocortisone—allergic rhinitis	0.000156	0.000601	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000155	0.000599	CcSEcCtD
Temsirolimus—MTOR—TSLP Signaling Pathway—NFKB1—allergic rhinitis	0.000154	0.00854	CbGpPWpGaD
Temsirolimus—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000153	0.000592	CcSEcCtD
Temsirolimus—Oedema—Prednisolone—allergic rhinitis	0.000153	0.000592	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	0.000152	0.00841	CbGpPWpGaD
Temsirolimus—Cough—Triamcinolone—allergic rhinitis	0.000151	0.000582	CcSEcCtD
Temsirolimus—Oedema—Hydrocortisone—allergic rhinitis	0.00015	0.000578	CcSEcCtD
Temsirolimus—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.00015	0.000578	CcSEcCtD
Temsirolimus—Convulsion—Triamcinolone—allergic rhinitis	0.00015	0.000578	CcSEcCtD
Temsirolimus—Convulsion—Methylprednisolone—allergic rhinitis	0.000149	0.000577	CcSEcCtD
Temsirolimus—Hypertension—Triamcinolone—allergic rhinitis	0.000149	0.000576	CcSEcCtD
Temsirolimus—Hypertension—Methylprednisolone—allergic rhinitis	0.000149	0.000575	CcSEcCtD
Temsirolimus—Infection—Hydrocortisone—allergic rhinitis	0.000149	0.000574	CcSEcCtD
Temsirolimus—MTOR—IL12-mediated signaling events—CD4—allergic rhinitis	0.000147	0.00815	CbGpPWpGaD
Temsirolimus—Myalgia—Triamcinolone—allergic rhinitis	0.000147	0.000568	CcSEcCtD
Temsirolimus—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000147	0.000567	CcSEcCtD
Temsirolimus—Myalgia—Methylprednisolone—allergic rhinitis	0.000147	0.000567	CcSEcCtD
Temsirolimus—Arthralgia—Methylprednisolone—allergic rhinitis	0.000147	0.000567	CcSEcCtD
Temsirolimus—Anxiety—Methylprednisolone—allergic rhinitis	0.000146	0.000565	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000146	0.000563	CcSEcCtD
Temsirolimus—Skin disorder—Hydrocortisone—allergic rhinitis	0.000145	0.000562	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IL13—allergic rhinitis	0.000143	0.00793	CbGpPWpGaD
Temsirolimus—Angioedema—Betamethasone—allergic rhinitis	0.000143	0.000553	CcSEcCtD
Temsirolimus—Angioedema—Dexamethasone—allergic rhinitis	0.000143	0.000553	CcSEcCtD
Temsirolimus—ABCB1—lung—allergic rhinitis	0.000143	0.0106	CbGeAlD
Temsirolimus—Anorexia—Hydrocortisone—allergic rhinitis	0.000143	0.000551	CcSEcCtD
Temsirolimus—Oedema—Triamcinolone—allergic rhinitis	0.000141	0.000544	CcSEcCtD
Temsirolimus—Anaphylactic shock—Triamcinolone—allergic rhinitis	0.000141	0.000544	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methylprednisolone—allergic rhinitis	0.000141	0.000543	CcSEcCtD
Temsirolimus—Infection—Triamcinolone—allergic rhinitis	0.00014	0.000541	CcSEcCtD
Temsirolimus—Infection—Methylprednisolone—allergic rhinitis	0.00014	0.00054	CcSEcCtD
Temsirolimus—Insomnia—Prednisolone—allergic rhinitis	0.000139	0.000535	CcSEcCtD
Temsirolimus—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000138	0.000533	CcSEcCtD
Temsirolimus—Skin disorder—Methylprednisolone—allergic rhinitis	0.000137	0.000528	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000136	0.000527	CcSEcCtD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000136	0.00753	CbGpPWpGaD
Temsirolimus—MTOR—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	0.000136	0.00753	CbGpPWpGaD
Temsirolimus—Convulsion—Betamethasone—allergic rhinitis	0.000136	0.000524	CcSEcCtD
Temsirolimus—Convulsion—Dexamethasone—allergic rhinitis	0.000136	0.000524	CcSEcCtD
Temsirolimus—Insomnia—Hydrocortisone—allergic rhinitis	0.000135	0.000523	CcSEcCtD
Temsirolimus—Hypertension—Betamethasone—allergic rhinitis	0.000135	0.000523	CcSEcCtD
Temsirolimus—Hypertension—Dexamethasone—allergic rhinitis	0.000135	0.000523	CcSEcCtD
Temsirolimus—Myalgia—Betamethasone—allergic rhinitis	0.000133	0.000515	CcSEcCtD
Temsirolimus—Myalgia—Dexamethasone—allergic rhinitis	0.000133	0.000515	CcSEcCtD
Temsirolimus—MTOR—Costimulation by the CD28 family—CD4—allergic rhinitis	0.000133	0.00737	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MS4A2—allergic rhinitis	0.000133	0.00737	CbGpPWpGaD
Temsirolimus—Anxiety—Dexamethasone—allergic rhinitis	0.000133	0.000513	CcSEcCtD
Temsirolimus—Anxiety—Betamethasone—allergic rhinitis	0.000133	0.000513	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	0.000132	0.00729	CbGpPWpGaD
Temsirolimus—Pain—Prednisolone—allergic rhinitis	0.000131	0.000506	CcSEcCtD
Temsirolimus—Decreased appetite—Hydrocortisone—allergic rhinitis	0.00013	0.000503	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000129	0.000499	CcSEcCtD
Temsirolimus—Fatigue—Hydrocortisone—allergic rhinitis	0.000129	0.000498	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000128	0.000496	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000128	0.000495	CcSEcCtD
Temsirolimus—Pain—Hydrocortisone—allergic rhinitis	0.000128	0.000494	CcSEcCtD
Temsirolimus—Anaphylactic shock—Dexamethasone—allergic rhinitis	0.000128	0.000494	CcSEcCtD
Temsirolimus—Oedema—Betamethasone—allergic rhinitis	0.000128	0.000494	CcSEcCtD
Temsirolimus—Anaphylactic shock—Betamethasone—allergic rhinitis	0.000128	0.000494	CcSEcCtD
Temsirolimus—Oedema—Dexamethasone—allergic rhinitis	0.000128	0.000494	CcSEcCtD
Temsirolimus—Insomnia—Triamcinolone—allergic rhinitis	0.000127	0.000492	CcSEcCtD
Temsirolimus—Insomnia—Methylprednisolone—allergic rhinitis	0.000127	0.000491	CcSEcCtD
Temsirolimus—Infection—Dexamethasone—allergic rhinitis	0.000127	0.000491	CcSEcCtD
Temsirolimus—Infection—Betamethasone—allergic rhinitis	0.000127	0.000491	CcSEcCtD
Temsirolimus—MTOR—IL12-mediated signaling events—NFKB1—allergic rhinitis	0.000127	0.00702	CbGpPWpGaD
Temsirolimus—Dyspnoea—Triamcinolone—allergic rhinitis	0.000126	0.000485	CcSEcCtD
Temsirolimus—Nervous system disorder—Betamethasone—allergic rhinitis	0.000125	0.000484	CcSEcCtD
Temsirolimus—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000125	0.000484	CcSEcCtD
Temsirolimus—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000125	0.000484	CcSEcCtD
Temsirolimus—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000125	0.000484	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IL5—allergic rhinitis	0.000123	0.00678	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000122	0.000473	CcSEcCtD
Temsirolimus—Anorexia—Dexamethasone—allergic rhinitis	0.000122	0.000471	CcSEcCtD
Temsirolimus—Anorexia—Betamethasone—allergic rhinitis	0.000122	0.000471	CcSEcCtD
Temsirolimus—Fatigue—Triamcinolone—allergic rhinitis	0.000121	0.000469	CcSEcCtD
Temsirolimus—Fatigue—Methylprednisolone—allergic rhinitis	0.000121	0.000468	CcSEcCtD
Temsirolimus—Pain—Triamcinolone—allergic rhinitis	0.00012	0.000466	CcSEcCtD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000119	0.00659	CbGpPWpGaD
Temsirolimus—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000118	0.000457	CcSEcCtD
Temsirolimus—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000118	0.000457	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000116	0.00045	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000116	0.00045	CcSEcCtD
Temsirolimus—Insomnia—Betamethasone—allergic rhinitis	0.000116	0.000447	CcSEcCtD
Temsirolimus—Insomnia—Dexamethasone—allergic rhinitis	0.000116	0.000447	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000115	0.000444	CcSEcCtD
Temsirolimus—MTOR—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000115	0.00635	CbGpPWpGaD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000113	0.00627	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Prednisolone—allergic rhinitis	0.000113	0.000436	CcSEcCtD
Temsirolimus—MTOR—CXCR4-mediated signaling events—CD4—allergic rhinitis	0.000113	0.00623	CbGpPWpGaD
Temsirolimus—Body temperature increased—Triamcinolone—allergic rhinitis	0.000111	0.00043	CcSEcCtD
Temsirolimus—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000111	0.000429	CcSEcCtD
Temsirolimus—Decreased appetite—Betamethasone—allergic rhinitis	0.000111	0.000429	CcSEcCtD
Temsirolimus—Decreased appetite—Dexamethasone—allergic rhinitis	0.000111	0.000429	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.00011	0.000426	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.00011	0.000426	CcSEcCtD
Temsirolimus—Hypersensitivity—Hydrocortisone—allergic rhinitis	0.00011	0.000426	CcSEcCtD
Temsirolimus—Fatigue—Dexamethasone—allergic rhinitis	0.00011	0.000426	CcSEcCtD
Temsirolimus—Fatigue—Betamethasone—allergic rhinitis	0.00011	0.000426	CcSEcCtD
Temsirolimus—FKBP1A—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000109	0.00605	CbGpPWpGaD
Temsirolimus—Pain—Dexamethasone—allergic rhinitis	0.000109	0.000422	CcSEcCtD
Temsirolimus—Pain—Betamethasone—allergic rhinitis	0.000109	0.000422	CcSEcCtD
Temsirolimus—Asthenia—Hydrocortisone—allergic rhinitis	0.000107	0.000415	CcSEcCtD
Temsirolimus—MTOR—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000106	0.00587	CbGpPWpGaD
Temsirolimus—Pruritus—Hydrocortisone—allergic rhinitis	0.000106	0.000409	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000105	0.000404	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000105	0.000404	CcSEcCtD
Temsirolimus—Hypersensitivity—Triamcinolone—allergic rhinitis	0.000104	0.000401	CcSEcCtD
Temsirolimus—Hypersensitivity—Methylprednisolone—allergic rhinitis	0.000104	0.0004	CcSEcCtD
Temsirolimus—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000102	0.000396	CcSEcCtD
Temsirolimus—Dizziness—Prednisolone—allergic rhinitis	0.000101	0.000391	CcSEcCtD
Temsirolimus—Asthenia—Triamcinolone—allergic rhinitis	0.000101	0.000391	CcSEcCtD
Temsirolimus—Body temperature increased—Betamethasone—allergic rhinitis	0.000101	0.00039	CcSEcCtD
Temsirolimus—Abdominal pain—Betamethasone—allergic rhinitis	0.000101	0.00039	CcSEcCtD
Temsirolimus—Body temperature increased—Dexamethasone—allergic rhinitis	0.000101	0.00039	CcSEcCtD
Temsirolimus—Abdominal pain—Dexamethasone—allergic rhinitis	0.000101	0.00039	CcSEcCtD
Temsirolimus—Asthenia—Methylprednisolone—allergic rhinitis	0.000101	0.00039	CcSEcCtD
Temsirolimus—Pruritus—Triamcinolone—allergic rhinitis	9.97e-05	0.000385	CcSEcCtD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	9.96e-05	0.00551	CbGpPWpGaD
Temsirolimus—Pruritus—Methylprednisolone—allergic rhinitis	9.95e-05	0.000384	CcSEcCtD
Temsirolimus—Dizziness—Hydrocortisone—allergic rhinitis	9.89e-05	0.000382	CcSEcCtD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	9.7e-05	0.00536	CbGpPWpGaD
Temsirolimus—Rash—Prednisolone—allergic rhinitis	9.66e-05	0.000373	CcSEcCtD
Temsirolimus—Dermatitis—Prednisolone—allergic rhinitis	9.65e-05	0.000373	CcSEcCtD
Temsirolimus—Diarrhoea—Methylprednisolone—allergic rhinitis	9.62e-05	0.000372	CcSEcCtD
Temsirolimus—Headache—Prednisolone—allergic rhinitis	9.6e-05	0.000371	CcSEcCtD
Temsirolimus—MTOR—Regulation of Telomerase—TGFB1—allergic rhinitis	9.57e-05	0.00529	CbGpPWpGaD
Temsirolimus—Vomiting—Hydrocortisone—allergic rhinitis	9.51e-05	0.000368	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	9.49e-05	0.00525	CbGpPWpGaD
Temsirolimus—Rash—Hydrocortisone—allergic rhinitis	9.43e-05	0.000365	CcSEcCtD
Temsirolimus—Dermatitis—Hydrocortisone—allergic rhinitis	9.42e-05	0.000364	CcSEcCtD
Temsirolimus—Headache—Hydrocortisone—allergic rhinitis	9.37e-05	0.000362	CcSEcCtD
Temsirolimus—Dizziness—Triamcinolone—allergic rhinitis	9.32e-05	0.00036	CcSEcCtD
Temsirolimus—Dizziness—Methylprednisolone—allergic rhinitis	9.3e-05	0.000359	CcSEcCtD
Temsirolimus—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	9.21e-05	0.0051	CbGpPWpGaD
Temsirolimus—Asthenia—Betamethasone—allergic rhinitis	9.17e-05	0.000354	CcSEcCtD
Temsirolimus—Asthenia—Dexamethasone—allergic rhinitis	9.17e-05	0.000354	CcSEcCtD
Temsirolimus—Nausea—Prednisolone—allergic rhinitis	9.1e-05	0.000352	CcSEcCtD
Temsirolimus—Pruritus—Dexamethasone—allergic rhinitis	9.04e-05	0.000349	CcSEcCtD
Temsirolimus—Pruritus—Betamethasone—allergic rhinitis	9.04e-05	0.000349	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IL10—allergic rhinitis	8.96e-05	0.00496	CbGpPWpGaD
Temsirolimus—Vomiting—Triamcinolone—allergic rhinitis	8.96e-05	0.000346	CcSEcCtD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	8.94e-05	0.00494	CbGpPWpGaD
Temsirolimus—Vomiting—Methylprednisolone—allergic rhinitis	8.94e-05	0.000345	CcSEcCtD
Temsirolimus—Nausea—Hydrocortisone—allergic rhinitis	8.89e-05	0.000343	CcSEcCtD
Temsirolimus—Rash—Triamcinolone—allergic rhinitis	8.88e-05	0.000343	CcSEcCtD
Temsirolimus—Dermatitis—Triamcinolone—allergic rhinitis	8.87e-05	0.000343	CcSEcCtD
Temsirolimus—Rash—Methylprednisolone—allergic rhinitis	8.86e-05	0.000342	CcSEcCtD
Temsirolimus—Dermatitis—Methylprednisolone—allergic rhinitis	8.85e-05	0.000342	CcSEcCtD
Temsirolimus—Headache—Triamcinolone—allergic rhinitis	8.83e-05	0.000341	CcSEcCtD
Temsirolimus—Headache—Methylprednisolone—allergic rhinitis	8.81e-05	0.00034	CcSEcCtD
Temsirolimus—Diarrhoea—Betamethasone—allergic rhinitis	8.75e-05	0.000338	CcSEcCtD
Temsirolimus—Diarrhoea—Dexamethasone—allergic rhinitis	8.75e-05	0.000338	CcSEcCtD
Temsirolimus—ABCB1—Allograft Rejection—IL4—allergic rhinitis	8.72e-05	0.00482	CbGpPWpGaD
Temsirolimus—Dizziness—Betamethasone—allergic rhinitis	8.45e-05	0.000327	CcSEcCtD
Temsirolimus—Dizziness—Dexamethasone—allergic rhinitis	8.45e-05	0.000327	CcSEcCtD
Temsirolimus—Nausea—Triamcinolone—allergic rhinitis	8.37e-05	0.000323	CcSEcCtD
Temsirolimus—Nausea—Methylprednisolone—allergic rhinitis	8.35e-05	0.000323	CcSEcCtD
Temsirolimus—Vomiting—Betamethasone—allergic rhinitis	8.13e-05	0.000314	CcSEcCtD
Temsirolimus—Vomiting—Dexamethasone—allergic rhinitis	8.13e-05	0.000314	CcSEcCtD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	8.08e-05	0.00447	CbGpPWpGaD
Temsirolimus—Rash—Betamethasone—allergic rhinitis	8.06e-05	0.000311	CcSEcCtD
Temsirolimus—Rash—Dexamethasone—allergic rhinitis	8.06e-05	0.000311	CcSEcCtD
Temsirolimus—Dermatitis—Betamethasone—allergic rhinitis	8.05e-05	0.000311	CcSEcCtD
Temsirolimus—Dermatitis—Dexamethasone—allergic rhinitis	8.05e-05	0.000311	CcSEcCtD
Temsirolimus—Headache—Betamethasone—allergic rhinitis	8.01e-05	0.000309	CcSEcCtD
Temsirolimus—Headache—Dexamethasone—allergic rhinitis	8.01e-05	0.000309	CcSEcCtD
Temsirolimus—MTOR—Immune System—MS4A2—allergic rhinitis	7.76e-05	0.00429	CbGpPWpGaD
Temsirolimus—Nausea—Betamethasone—allergic rhinitis	7.59e-05	0.000293	CcSEcCtD
Temsirolimus—Nausea—Dexamethasone—allergic rhinitis	7.59e-05	0.000293	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—PTGDR2—allergic rhinitis	7.59e-05	0.0042	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.45e-05	0.00412	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-G—allergic rhinitis	6.91e-05	0.00382	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	6.76e-05	0.00374	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—NFKB1—allergic rhinitis	6.3e-05	0.00349	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	6.07e-05	0.00336	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CYSLTR1—allergic rhinitis	5.96e-05	0.00329	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL11—allergic rhinitis	5.75e-05	0.00318	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	5.6e-05	0.0031	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	5.34e-05	0.00296	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—NFKB1—allergic rhinitis	4.94e-05	0.00273	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.31e-05	0.00239	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTGDR2—allergic rhinitis	4.27e-05	0.00236	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-G—allergic rhinitis	4.19e-05	0.00232	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TAC1—allergic rhinitis	4.18e-05	0.00231	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SMAD3—allergic rhinitis	3.9e-05	0.00216	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL5—allergic rhinitis	3.88e-05	0.00215	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—NFKB1—allergic rhinitis	3.88e-05	0.00215	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	3.65e-05	0.00202	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NFKB1—allergic rhinitis	3.64e-05	0.00201	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL5—allergic rhinitis	3.38e-05	0.00187	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CYSLTR1—allergic rhinitis	3.35e-05	0.00185	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL11—allergic rhinitis	3.23e-05	0.00179	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ICAM1—allergic rhinitis	3.15e-05	0.00174	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SMAD3—allergic rhinitis	2.73e-05	0.00151	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DQB1—allergic rhinitis	2.62e-05	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—allergic rhinitis	2.41e-05	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TAC1—allergic rhinitis	2.35e-05	0.0013	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—allergic rhinitis	2.31e-05	0.00128	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—allergic rhinitis	2.3e-05	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SMAD3—allergic rhinitis	2.2e-05	0.00121	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL5—allergic rhinitis	2.18e-05	0.00121	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.16e-05	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NFKB1—allergic rhinitis	2.08e-05	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—NFKB1—allergic rhinitis	1.99e-05	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ICAM1—allergic rhinitis	1.91e-05	0.00106	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.8e-05	0.000997	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—allergic rhinitis	1.65e-05	0.000915	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SMAD3—allergic rhinitis	1.54e-05	0.000851	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—allergic rhinitis	1.4e-05	0.000776	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NFKB1—allergic rhinitis	1.39e-05	0.000769	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—allergic rhinitis	1.3e-05	0.000717	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NFKB1—allergic rhinitis	1.21e-05	0.000669	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—allergic rhinitis	1.16e-05	0.00064	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—allergic rhinitis	9.3e-06	0.000514	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFKB1—allergic rhinitis	7.82e-06	0.000432	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—allergic rhinitis	6.51e-06	0.00036	CbGpPWpGaD
